Skip to main content
. 2018 Dec 15;16:130–140. doi: 10.1016/j.omtn.2018.12.006

Figure 4.

Figure 4

Immunocytochemistry Reveals Higher Positive Expression of CARM1 in NSCLC Tissues (n = 80)

(A) Immunocytochemistry (×400) and (B) CARM1 positive expression. *p < 0.05, compared with the adjacent tissues. NSCLC, non-small cell lung cancer; CARM1, co-activator-associated arginine methyltransferase 1.